nodes	percent_of_prediction	percent_of_DWPC	metapath
Droperidol—KCNH2—purkinje fiber—dilated cardiomyopathy	0.33	0.506	CbGeAlD
Droperidol—KCNH2—endocardium—dilated cardiomyopathy	0.17	0.261	CbGeAlD
Droperidol—HTR2A—pulmonary artery—dilated cardiomyopathy	0.0461	0.0706	CbGeAlD
Droperidol—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.0449	0.0687	CbGeAlD
Droperidol—Hypovolaemia—Furosemide—dilated cardiomyopathy	0.0287	0.138	CcSEcCtD
Droperidol—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.0186	0.0893	CcSEcCtD
Droperidol—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.0146	0.0702	CcSEcCtD
Droperidol—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.0143	0.0219	CbGeAlD
Droperidol—KCNH2—myocardium—dilated cardiomyopathy	0.0135	0.0206	CbGeAlD
Droperidol—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.0115	0.0551	CcSEcCtD
Droperidol—ADRA1A—heart—dilated cardiomyopathy	0.00974	0.0149	CbGeAlD
Droperidol—KCNH2—heart—dilated cardiomyopathy	0.00941	0.0144	CbGeAlD
Droperidol—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00916	0.0439	CcSEcCtD
Droperidol—KCNH2—cardiac atrium—dilated cardiomyopathy	0.00804	0.0123	CbGeAlD
Droperidol—ADRA1A—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.00737	0.0561	CbGpPWpGaD
Droperidol—KCNH2—Hematopoietic Stem Cell Differentiation—CSF3—dilated cardiomyopathy	0.00695	0.0529	CbGpPWpGaD
Droperidol—Fluspirilene—ADRB1—dilated cardiomyopathy	0.00687	1	CrCbGaD
Droperidol—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00668	0.032	CcSEcCtD
Droperidol—HTR2A—heart—dilated cardiomyopathy	0.0063	0.00964	CbGeAlD
Droperidol—ADRA1A—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.00597	0.0454	CbGpPWpGaD
Droperidol—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00584	0.028	CcSEcCtD
Droperidol—Somnolence—Spironolactone—dilated cardiomyopathy	0.00519	0.0249	CcSEcCtD
Droperidol—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00504	0.0241	CcSEcCtD
Droperidol—Drowsiness—Furosemide—dilated cardiomyopathy	0.00498	0.0239	CcSEcCtD
Droperidol—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00462	0.0221	CcSEcCtD
Droperidol—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00461	0.0221	CcSEcCtD
Droperidol—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0043	0.0206	CcSEcCtD
Droperidol—KCNH2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00421	0.032	CbGpPWpGaD
Droperidol—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00412	0.0198	CcSEcCtD
Droperidol—KCNH2—Potassium Channels—ABCC9—dilated cardiomyopathy	0.0039	0.0297	CbGpPWpGaD
Droperidol—Dizziness—Spironolactone—dilated cardiomyopathy	0.00386	0.0185	CcSEcCtD
Droperidol—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00378	0.0181	CcSEcCtD
Droperidol—Depression—Lisinopril—dilated cardiomyopathy	0.00373	0.0179	CcSEcCtD
Droperidol—Rash—Spironolactone—dilated cardiomyopathy	0.00368	0.0176	CcSEcCtD
Droperidol—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00368	0.0176	CcSEcCtD
Droperidol—Hallucination—Lisinopril—dilated cardiomyopathy	0.00334	0.016	CcSEcCtD
Droperidol—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00318	0.0152	CcSEcCtD
Droperidol—Shock—Furosemide—dilated cardiomyopathy	0.00313	0.015	CcSEcCtD
Droperidol—Chills—Lisinopril—dilated cardiomyopathy	0.00301	0.0144	CcSEcCtD
Droperidol—KCNH2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.003	0.0228	CbGpPWpGaD
Droperidol—Hypotension—Furosemide—dilated cardiomyopathy	0.00297	0.0142	CcSEcCtD
Droperidol—Somnolence—Furosemide—dilated cardiomyopathy	0.00282	0.0135	CcSEcCtD
Droperidol—DRD2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00271	0.0206	CbGpPWpGaD
Droperidol—Angioedema—Lisinopril—dilated cardiomyopathy	0.00267	0.0128	CcSEcCtD
Droperidol—HTR2A—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00266	0.0202	CbGpPWpGaD
Droperidol—Syncope—Lisinopril—dilated cardiomyopathy	0.00262	0.0125	CcSEcCtD
Droperidol—ADRA1A—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00261	0.0198	CbGpPWpGaD
Droperidol—ADRA1A—Endothelin Pathways—ADRB1—dilated cardiomyopathy	0.00261	0.0198	CbGpPWpGaD
Droperidol—Palpitations—Lisinopril—dilated cardiomyopathy	0.00258	0.0124	CcSEcCtD
Droperidol—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00257	0.0123	CcSEcCtD
Droperidol—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00251	0.012	CcSEcCtD
Droperidol—DRD2—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.0025	0.019	CbGpPWpGaD
Droperidol—Anxiety—Lisinopril—dilated cardiomyopathy	0.00248	0.0119	CcSEcCtD
Droperidol—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00238	0.0114	CcSEcCtD
Droperidol—Shock—Lisinopril—dilated cardiomyopathy	0.00235	0.0112	CcSEcCtD
Droperidol—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00234	0.0112	CcSEcCtD
Droperidol—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00233	0.0111	CcSEcCtD
Droperidol—HTR2A—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00228	0.0173	CbGpPWpGaD
Droperidol—DRD2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00227	0.0173	CbGpPWpGaD
Droperidol—HTR2A—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00224	0.017	CbGpPWpGaD
Droperidol—Hypotension—Lisinopril—dilated cardiomyopathy	0.00223	0.0107	CcSEcCtD
Droperidol—DRD2—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00219	0.0167	CbGpPWpGaD
Droperidol—ADRA1A—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00219	0.0167	CbGpPWpGaD
Droperidol—HTR2A—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00216	0.0164	CbGpPWpGaD
Droperidol—Somnolence—Lisinopril—dilated cardiomyopathy	0.00212	0.0102	CcSEcCtD
Droperidol—ADRA1A—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00211	0.0161	CbGpPWpGaD
Droperidol—Dizziness—Furosemide—dilated cardiomyopathy	0.0021	0.0101	CcSEcCtD
Droperidol—Rash—Furosemide—dilated cardiomyopathy	0.002	0.0096	CcSEcCtD
Droperidol—Dermatitis—Furosemide—dilated cardiomyopathy	0.002	0.00959	CcSEcCtD
Droperidol—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00188	0.00903	CcSEcCtD
Droperidol—DRD2—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00184	0.014	CbGpPWpGaD
Droperidol—HTR2A—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00181	0.0138	CbGpPWpGaD
Droperidol—ADRA1A—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00178	0.0135	CbGpPWpGaD
Droperidol—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00176	0.00841	CcSEcCtD
Droperidol—KCNH2—Neuronal System—ABCC9—dilated cardiomyopathy	0.0017	0.0129	CbGpPWpGaD
Droperidol—HTR2A—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—RAF1—dilated cardiomyopathy	0.00166	0.0126	CbGpPWpGaD
Droperidol—ADRA1A—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00165	0.0126	CbGpPWpGaD
Droperidol—KCNH2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00163	0.0124	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00162	0.0124	CbGpPWpGaD
Droperidol—ADRA1A—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00161	0.0122	CbGpPWpGaD
Droperidol—Dizziness—Lisinopril—dilated cardiomyopathy	0.00158	0.00755	CcSEcCtD
Droperidol—Rash—Lisinopril—dilated cardiomyopathy	0.0015	0.0072	CcSEcCtD
Droperidol—Dermatitis—Lisinopril—dilated cardiomyopathy	0.0015	0.00719	CcSEcCtD
Droperidol—DRD2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00138	0.0105	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00136	0.0103	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00133	0.0101	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.00122	0.00929	CbGpPWpGaD
Droperidol—KCNH2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00117	0.0089	CbGpPWpGaD
Droperidol—ADRA1A—Endothelin Pathways—RAF1—dilated cardiomyopathy	0.00109	0.00827	CbGpPWpGaD
Droperidol—KCNH2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00101	0.00772	CbGpPWpGaD
Droperidol—ADRA1A—AMPK Signaling—RPS6KB1—dilated cardiomyopathy	0.00101	0.00765	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.000958	0.00729	CbGpPWpGaD
Droperidol—ADRA1A—G alpha (12/13) signalling events—RAC1—dilated cardiomyopathy	0.00085	0.00647	CbGpPWpGaD
Droperidol—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000781	0.00594	CbGpPWpGaD
Droperidol—ADRA1A—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000644	0.0049	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000634	0.00482	CbGpPWpGaD
Droperidol—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000633	0.00481	CbGpPWpGaD
Droperidol—DRD2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000625	0.00475	CbGpPWpGaD
Droperidol—DRD2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000625	0.00475	CbGpPWpGaD
Droperidol—DRD2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000581	0.00442	CbGpPWpGaD
Droperidol—DRD2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00058	0.00441	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000571	0.00434	CbGpPWpGaD
Droperidol—HTR2A—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.000568	0.00432	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000559	0.00425	CbGpPWpGaD
Droperidol—ADRA1A—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.000556	0.00423	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00055	0.00418	CbGpPWpGaD
Droperidol—DRD2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000539	0.0041	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000531	0.00403	CbGpPWpGaD
Droperidol—DRD2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000522	0.00397	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00052	0.00395	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000514	0.00391	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000508	0.00386	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000503	0.00383	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000497	0.00378	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000497	0.00378	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000497	0.00378	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000489	0.00372	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000489	0.00372	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000479	0.00364	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000479	0.00364	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000462	0.00351	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000455	0.00346	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000447	0.0034	CbGpPWpGaD
Droperidol—DRD2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000446	0.00339	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000445	0.00338	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00044	0.00335	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000439	0.00334	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000431	0.00328	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00043	0.00327	CbGpPWpGaD
Droperidol—DRD2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000423	0.00322	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000416	0.00317	CbGpPWpGaD
Droperidol—DRD2—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000409	0.00311	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000408	0.0031	CbGpPWpGaD
Droperidol—HTR2A—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.0004	0.00304	CbGpPWpGaD
Droperidol—ADRA1A—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000391	0.00297	CbGpPWpGaD
Droperidol—KCNH2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000386	0.00294	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000382	0.00291	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000378	0.00288	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000378	0.00288	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000376	0.00286	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000372	0.00283	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000372	0.00283	CbGpPWpGaD
Droperidol—KCNH2—Neuronal System—RAF1—dilated cardiomyopathy	0.000371	0.00282	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000368	0.0028	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000365	0.00277	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000365	0.00277	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000363	0.00276	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000357	0.00272	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000357	0.00271	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000352	0.00268	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00035	0.00266	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000349	0.00266	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000346	0.00263	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000341	0.00259	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000339	0.00258	CbGpPWpGaD
Droperidol—DRD2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000338	0.00257	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000335	0.00255	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000328	0.0025	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000291	0.00221	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000286	0.00218	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00028	0.00213	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000276	0.0021	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000272	0.00207	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000269	0.00204	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000266	0.00202	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000265	0.00201	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000259	0.00197	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000248	0.00189	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000243	0.00185	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000214	0.00163	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000214	0.00163	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00021	0.0016	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00021	0.0016	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000209	0.00159	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000206	0.00157	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000206	0.00157	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000205	0.00156	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000201	0.00153	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000199	0.00151	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000197	0.0015	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000196	0.00149	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000194	0.00148	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000194	0.00148	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000193	0.00146	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000192	0.00146	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000191	0.00145	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000191	0.00145	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000189	0.00144	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000187	0.00142	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000187	0.00142	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000186	0.00141	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000181	0.00137	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000178	0.00135	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000175	0.00133	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000174	0.00132	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000172	0.00131	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00017	0.00129	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000168	0.00128	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000167	0.00127	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000164	0.00125	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000162	0.00123	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000158	0.0012	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000156	0.00119	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000154	0.00117	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00015	0.00114	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000149	0.00114	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000147	0.00112	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000144	0.00109	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000142	0.00108	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000139	0.00106	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000136	0.00104	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000129	0.000982	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000127	0.000967	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000124	0.000947	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000121	0.000921	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000119	0.000906	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000117	0.000887	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000116	0.00088	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000115	0.000872	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000115	0.000872	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000114	0.000866	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000113	0.000858	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000113	0.000858	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000111	0.000848	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000111	0.00084	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000111	0.00084	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00011	0.000836	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000108	0.000823	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000107	0.000811	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000106	0.000806	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000105	0.000799	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000105	0.000798	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000103	0.000786	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000103	0.000785	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000103	0.000781	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000102	0.000773	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000101	0.00077	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.95e-05	0.000757	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.82e-05	0.000671	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.68e-05	0.00066	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.5e-05	0.000646	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.37e-05	0.000636	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.23e-05	0.000626	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.06e-05	0.000613	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.29e-05	0.000555	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.19e-05	0.000547	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.18e-05	0.000546	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.08e-05	0.000538	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.03e-05	0.000534	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.93e-05	0.000527	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	6.5e-05	0.000494	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	6.39e-05	0.000486	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	6.26e-05	0.000476	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	6.21e-05	0.000472	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	6.11e-05	0.000464	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	5.98e-05	0.000455	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	5e-05	0.00038	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.92e-05	0.000374	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.82e-05	0.000366	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	4.31e-05	0.000328	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.24e-05	0.000322	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.15e-05	0.000316	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.95e-05	0.000225	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.91e-05	0.000221	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.85e-05	0.000216	CbGpPWpGaD
